Nanding, Abdulrahman .

HRN: 15-57-71  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/28/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/28/2023
09/04/2023
IV
600mg
Q8H
Scrotal Abscess
Waiting Final Action 
08/29/2023
MUPIROCIN 2%, 15G (TUBE)
08/29/2023
09/04/2023
TOPICAL
2%
BID
Scrotal Abscess
Waiting Final Action 
08/30/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/30/2023
09/06/2023
IV
1.5gram
Q6
Scrotal Abscess
Waiting Final Action 
09/07/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/07/2023
09/13/2023
IV
4.5g
Q6
Scrotal Abscess
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: